Patents by Inventor ALICJA JOZKOWICZ

ALICJA JOZKOWICZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cobalt porphyrins for the treatment of blood-related disorders
    Patent number: 10328085
    Abstract: The use of cobalt porphyrins for the manufacture of an agent for mobilizing bone marrow cells to peripheral blood, preferably used to treat congenital neutropenia, for the treatment and prevention of neutropenia caused by chemotherapy, radiotherapy and pharmacologically-induced neutropenia, for the treatment of acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes, and to increase the amount of circulating hematopoietic stem cells in peripheral blood for subsequent isolation in the process of apheresis and allogeneic or autologous transplantation.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: June 25, 2019
    Assignee: UNIWERSYTET JAGIELLONSKI
    Inventors: Agata Szade, Krzysztof Szade, Alicja Jozkowicz, Jozef Dulak
  • COBALT PORPHYRINS FOR THE TREATMENT OF BLOOD-RELATED DISORDERS
    Publication number: 20180296569
    Abstract: The use of cobalt porphyrins for the manufacture of an agent for mobilizing bone marrow cells to peripheral blood, preferably used to treat congenital neutropenia, for the treatment and prevention of neutropenia caused by chemotherapy, radiotherapy and pharmacologically-induced neutropenia, for the treatment of acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes, and to increase the amount of circulating hematopoietic stem cells in peripheral blood for subsequent isolation in the process of apheresis and allogeneic or autologous transplantation.
    Type: Application
    Filed: June 26, 2018
    Publication date: October 18, 2018
    Inventors: AGATA SZADE, Krzysztof Szade, Alicja Jozkowicz, Jozef Dulak
  • Cobalt porphyrins for the treatment of blood-related disorders
    Patent number: 10010557
    Abstract: The use of cobalt porphyrins for the manufacture of an agent for mobilizing bone marrow cells to peripheral blood, preferably used to treat congenital neutropenia, for the treatment and prevention of neutropenia caused by chemotherapy, radiotherapy and pharmacologically-induced neutropenia, for the treatment of acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes, and to increase the amount of circulating hematopoietic stem cells in peripheral blood for subsequent isolation in the process of apheresis and allogeneic or autologous transplantation.
    Type: Grant
    Filed: May 9, 2015
    Date of Patent: July 3, 2018
    Assignee: UNIWERSYTET JAGIELLONSKI
    Inventors: Agata Szade, Krzysztof Szade, Alicja Jozkowicz, Jozef Dulak
  • COBALT PORPHYRINS FOR THE TREATMENT OF BLOOD-RELATED DISORDERS
    Publication number: 20170196882
    Abstract: The use of cobalt porphyrins for the manufacture of an agent for mobilizing bone marrow cells to peripheral blood, preferably used to treat congenital neutropenia, for the treatment and prevention of neutropenia caused by chemotherapy, radiotherapy and pharmacologically-induced neutropenia, for the treatment of acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes, and to increase the amount of circulating hematopoietic stem cells in peripheral blood for subsequent isolation in the process of apheresis and allogeneic or autologous transplantation.
    Type: Application
    Filed: May 9, 2015
    Publication date: July 13, 2017
    Inventors: AGATA SZADE, KRZYSZTOF SZADE, ALICJA JOZKOWICZ, JOZEF DULAK